Clinical Trials Directory

Trials / Sponsors / Altimmune, Inc.

Altimmune, Inc.

Industry · 19 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingRESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-A
Alcohol Liver Disease
Phase 22025-06-16
Active Not RecruitingRECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Dis
Alcohol Use Disorder (AUD)
Phase 22025-05-15
CompletedIMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
Non-Alcoholic Steatohepatitis (NASH)
Phase 22023-07-27
CompletedEfficacy and Safety of ALT-801 in the Treatment of Obesity
Obesity/Overweight
Phase 22022-03-31
CompletedExtension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)
Non-Alcoholic Fatty Liver Disease
Phase 12022-03-09
CompletedALT-801 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus (T2DM)
Type 2 Diabetes
Phase 12022-02-01
CompletedALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With Non-alcoholic Fatty Liver Disease (NAF
Non-Alcoholic Fatty Liver Disease
Phase 12021-09-30
CompletedPemvidutide (ALT-801) DDI Study in Healthy Volunteers
NASH - Nonalcoholic Steatohepatitis
Phase 12021-09-15
CompletedSafety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study)
Healthy Volunteers
Phase 12021-02-25
TerminatedHepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)
Hepatitis B, Chronic
Phase 22020-12-26
CompletedALT-801 (Pemvidutide) in Healthy Overweight and Obese Volunteers to Study Safety and Tolerability
Obesity, Nonalcoholic Steatohepatitis
Phase 12020-11-10
TerminatedNasoVAX in Patients With Early Coronavirus Infectious Disease 2019 (COVID-19)
Coronavirus Infection
Phase 22020-10-10
CompletedNasoShield in Healthy Adults to Study Safety and Immunogenicity
Healthy Volunteers
Phase 12020-06-15
CompletedStudy of the Safety and Immunogenicity of NasoVAX Extension
Influenza
—2019-01-21
CompletedNasoShield Study of Safety and Immunogenicity
Healthy Volunteers
Phase 12018-01-18
CompletedSingle-ascending-dose Study of the Safety and Immunogenicity of NasoVAX
Influenza
Phase 22017-09-18
CompletedImmune Response Following Seasonal Influenza Vaccination
Influenza
Phase 42017-05-08
CompletedPhase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B
Hepatitis B
Phase 12015-07-01
CompletedSafety and Immunogenicity Study of Adenovirus-vectored, Intranasal Pandemic Influenza Vaccine.
Influenza A Subtype H5N1 Infection
Phase 12008-10-01